Adam Logal
Director of Finance/CFO bei OPKO HEALTH, INC.
Vermögen: 214 997 $ am 31.03.2024
Aktive Positionen von Adam Logal
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
OPKO HEALTH, INC. | Comptroller/Controller/Auditor | 12.02.2021 | - |
Director of Finance/CFO | 31.03.2014 | - | |
Treasurer | 12.02.2021 | - | |
BIO-REFERENCE LABORATORIES INC | Director/Board Member | 20.08.2015 | - |
XENETIC BIOSCIENCES, INC. | Chairman | 14.08.2017 | - |
Independent Dir/Board Member | 14.08.2017 | - | |
OPKO Biologics Ltd.
OPKO Biologics Ltd. Pharmaceuticals: MajorHealth Technology OPKO Biologics Ltd. develops next-generation, bio-better, long-acting versions of therapeutic proteins and peptide drugs. Its products include Human Growth Hormone, Glucagon dual receptor agonist, Factor VIIa and Factor IX for Hemophilia, Anti-Obesity Peptide Oxyntomodulin, Interferon and Erythropoietin, and Atherosclerosis and Rheumatoid Arthritis long-acting therapies. The company was founded by Novik A. Shai on August 22, 2003 and is headquartered in Nes Ziona, Israel. | Director/Board Member | 01.04.2014 | - |
Karriereverlauf von Adam Logal
Ehemalige bekannte Positionen von Adam Logal
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
VBI VACCINES INC. | Director/Board Member | 01.05.2015 | 01.10.2018 |
Independent Dir/Board Member | 01.05.2015 | 01.10.2018 | |
eXegenics, Inc. | Comptroller/Controller/Auditor | 13.06.2007 | 13.06.2007 |
Director of Finance/CFO | 13.06.2007 | 13.06.2007 | |
Corporate Secretary | 13.06.2007 | 13.06.2007 | |
Treasurer | 13.06.2007 | 13.06.2007 | |
Nabi Biopharmaceuticals
Nabi Biopharmaceuticals BiotechnologyHealth Technology Nabi Biopharmaceuticals develops and manufactures biopharmaceutical products. It focuses on the development of vaccines addressing unmet medical needs, including gram-positive bacterial infections and nicotine addiction. The Nicotine Addiction area develops NicVAX, which is an innovative and proprietary investigational vaccine for the treatment of nicotine addiction and prevention of smoking relapse based on patented technology. Nabi Biopharmaceuticals was founded in 1969 and is headquartered in Rockville, MD. | Comptroller/Controller/Auditor | 01.01.2002 | 01.01.2007 |
Director of Finance/CFO | 01.01.2002 | 01.01.2007 | |
SciVac Therapeutics, Inc. | Director/Board Member | - | - |
Statistik
International
Vereinigte Staaten | 7 |
Israel | 3 |
Operativ
Director/Board Member | 4 |
Comptroller/Controller/Auditor | 3 |
Director of Finance/CFO | 3 |
Sektoral
Health Technology | 7 |
Health Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
OPKO HEALTH, INC. | Health Services |
XENETIC BIOSCIENCES, INC. | Health Technology |
VBI VACCINES INC. | Health Technology |
Private Unternehmen | 5 |
---|---|
Bio-Reference Laboratories, Inc.
Bio-Reference Laboratories, Inc. Medical/Nursing ServicesHealth Services Bio-Reference Laboratories, Inc. engages in the provision testing and related services to physicians, clinics, hospitals, long-term care facilities, employers, government units, and correctional institutions. It offers a list of chemical diagnostic tests, including blood and urine analysis, blood chemistry, hematology, services, serology, radio-immuno analysis, toxicology, pap smears, tissue pathology and other tissue analysis. The firm focuses on esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health, and correctional health care. The company was founded by Marc D. Grodman in 1981 and is headquartered in Elmwood Park, NJ. | Health Services |
Nabi Biopharmaceuticals
Nabi Biopharmaceuticals BiotechnologyHealth Technology Nabi Biopharmaceuticals develops and manufactures biopharmaceutical products. It focuses on the development of vaccines addressing unmet medical needs, including gram-positive bacterial infections and nicotine addiction. The Nicotine Addiction area develops NicVAX, which is an innovative and proprietary investigational vaccine for the treatment of nicotine addiction and prevention of smoking relapse based on patented technology. Nabi Biopharmaceuticals was founded in 1969 and is headquartered in Rockville, MD. | Health Technology |
eXegenics, Inc. | Health Technology |
OPKO Biologics Ltd.
OPKO Biologics Ltd. Pharmaceuticals: MajorHealth Technology OPKO Biologics Ltd. develops next-generation, bio-better, long-acting versions of therapeutic proteins and peptide drugs. Its products include Human Growth Hormone, Glucagon dual receptor agonist, Factor VIIa and Factor IX for Hemophilia, Anti-Obesity Peptide Oxyntomodulin, Interferon and Erythropoietin, and Atherosclerosis and Rheumatoid Arthritis long-acting therapies. The company was founded by Novik A. Shai on August 22, 2003 and is headquartered in Nes Ziona, Israel. | Health Technology |
SciVac Therapeutics, Inc. | Health Technology |
- Börse
- Insiders
- Adam Logal
- Erfahrung